z-logo
open-access-imgOpen Access
Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
Author(s) -
Naiyarat Prasongsook,
Aditi Kumar,
Ashish V. Chintakuntlawar,
Robert L. Foote,
Jan L. Kasperbauer,
Julian R. Molina,
Yolanda I. Garces,
J. Daniel,
Michelle A. Neben Wittich,
Joseph Rubin,
Ronald L. Richardson,
John H. Morris,
Ian Hay,
Vahab Fatourechi,
Bryan McIver,
Mabel Ryder,
Geoffrey B. Thompson,
Clive S. Grant,
Melanie L. Richards,
Thomas J. Sebo,
Michael Rivera,
Vera J. Suman,
Sarah M. Jenkins,
Robert C. Smallridge,
Keith C. Bible
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-01180
Subject(s) - medicine , cohort , hazard ratio , cancer , stage (stratigraphy) , anaplastic thyroid cancer , confidence interval , retrospective cohort study , surgery , proportional hazards model , thyroid cancer , paleontology , biology
Historical outcomes in anaplastic thyroid cancer (ATC) have been dismal.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom